MXPA05003909A - Compuestos de benzopiranona, composiciones de los mismos, y metodos para el tratamiento o prevencion del cancer. - Google Patents
Compuestos de benzopiranona, composiciones de los mismos, y metodos para el tratamiento o prevencion del cancer.Info
- Publication number
- MXPA05003909A MXPA05003909A MXPA05003909A MXPA05003909A MXPA05003909A MX PA05003909 A MXPA05003909 A MX PA05003909A MX PA05003909 A MXPA05003909 A MX PA05003909A MX PA05003909 A MXPA05003909 A MX PA05003909A MX PA05003909 A MXPA05003909 A MX PA05003909A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- treating
- methods
- benzopyranone
- preventing cancer
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical class C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- -1 Benzopyranone Compound Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000005170 neoplastic cell Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41846902P | 2002-10-15 | 2002-10-15 | |
| US10/685,722 US7091235B2 (en) | 2002-10-15 | 2003-10-14 | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| PCT/US2003/032932 WO2004035002A2 (en) | 2002-10-15 | 2003-10-15 | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05003909A true MXPA05003909A (es) | 2005-09-30 |
Family
ID=32110155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05003909A MXPA05003909A (es) | 2002-10-15 | 2003-10-15 | Compuestos de benzopiranona, composiciones de los mismos, y metodos para el tratamiento o prevencion del cancer. |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US7091235B2 (enExample) |
| EP (1) | EP1556374A4 (enExample) |
| JP (1) | JP2006515275A (enExample) |
| KR (1) | KR20050072764A (enExample) |
| CN (1) | CN100457751C (enExample) |
| AU (1) | AU2003286441A1 (enExample) |
| BR (1) | BR0315400A (enExample) |
| CA (1) | CA2502064A1 (enExample) |
| IL (1) | IL168059A0 (enExample) |
| MX (1) | MXPA05003909A (enExample) |
| NZ (1) | NZ539675A (enExample) |
| WO (1) | WO2004035002A2 (enExample) |
| ZA (1) | ZA200503026B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7091235B2 (en) * | 2002-10-15 | 2006-08-15 | Signal Pharmaceuticals, Llc | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| US7514438B2 (en) * | 2003-08-13 | 2009-04-07 | Amgen, Inc. | Melanin concentrating hormone receptor antagonist |
| CA2534428A1 (en) * | 2003-08-13 | 2005-03-03 | Paul A. Tempest | Melanin concentrating hormone receptor antagonists |
| AU2004274445A1 (en) * | 2003-09-15 | 2005-03-31 | Novartis Ag | Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| CA2595472A1 (en) | 2005-01-21 | 2006-07-27 | Janssen Pharmaceutica N.V. | Novel coumarin derivatives as ion channel openers |
| JP2008543944A (ja) * | 2005-06-24 | 2008-12-04 | シグナル ファーマシューティカルズ，エルエルシー | 癌を治療するためのベンゾピラノン化合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US633155A (en) | 1898-02-23 | 1899-09-19 | William W Ramsay | Fence-repairing tool. |
| US5633155A (en) * | 1992-08-19 | 1997-05-27 | Jinro Limited | Expression vector for phytolacca antiviral protein and process for preparing transgenic plant transformed therewith |
| US6444688B1 (en) * | 1995-06-07 | 2002-09-03 | Eli Lilly And Company | Compounds and compositions with nitrogen-containing non-basic side chains |
| US6291456B1 (en) | 1998-12-30 | 2001-09-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| JP2002533456A (ja) | 1998-12-30 | 2002-10-08 | シグナル ファーマシューティカルズ， インコーポレイテッド | エストロゲン受容体のモジュレートを行うための化合物および方法 |
| US6331562B1 (en) | 1998-12-30 | 2001-12-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| EP1246814B1 (en) | 1999-12-30 | 2005-02-16 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| US7148252B2 (en) | 2001-10-03 | 2006-12-12 | Signal Pharmaceuticals, Llc | Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis |
| AU2003239155B2 (en) * | 2002-04-19 | 2008-12-04 | Novartis Ag | Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| US6620838B1 (en) * | 2002-04-19 | 2003-09-16 | Signal Pharmaceuticals, Inc. | Benzopyrazone compounds, compositions thereof, and methods of treatment therewith |
| US7091235B2 (en) * | 2002-10-15 | 2006-08-15 | Signal Pharmaceuticals, Llc | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
-
2003
- 2003-10-14 US US10/685,722 patent/US7091235B2/en not_active Expired - Fee Related
- 2003-10-15 BR BR0315400-9A patent/BR0315400A/pt not_active IP Right Cessation
- 2003-10-15 MX MXPA05003909A patent/MXPA05003909A/es active IP Right Grant
- 2003-10-15 KR KR1020057006631A patent/KR20050072764A/ko not_active Ceased
- 2003-10-15 JP JP2004545432A patent/JP2006515275A/ja active Pending
- 2003-10-15 CN CNB2003801043358A patent/CN100457751C/zh not_active Expired - Fee Related
- 2003-10-15 ZA ZA200503025A patent/ZA200503026B/xx unknown
- 2003-10-15 CA CA002502064A patent/CA2502064A1/en not_active Abandoned
- 2003-10-15 WO PCT/US2003/032932 patent/WO2004035002A2/en not_active Ceased
- 2003-10-15 EP EP03777639A patent/EP1556374A4/en not_active Withdrawn
- 2003-10-15 NZ NZ539675A patent/NZ539675A/en unknown
- 2003-10-15 AU AU2003286441A patent/AU2003286441A1/en not_active Abandoned
-
2005
- 2005-04-14 IL IL168059A patent/IL168059A0/en unknown
-
2006
- 2006-05-09 US US11/431,056 patent/US7358274B2/en not_active Expired - Fee Related
-
2008
- 2008-02-22 US US12/072,011 patent/US7589119B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200503026B (en) | 2006-11-29 |
| US20040225005A1 (en) | 2004-11-11 |
| WO2004035002A2 (en) | 2004-04-29 |
| WO2004035002A3 (en) | 2004-08-26 |
| EP1556374A4 (en) | 2007-12-19 |
| CA2502064A1 (en) | 2004-04-29 |
| CN1717405A (zh) | 2006-01-04 |
| CN100457751C (zh) | 2009-02-04 |
| US7091235B2 (en) | 2006-08-15 |
| NZ539675A (en) | 2006-10-27 |
| JP2006515275A (ja) | 2006-05-25 |
| BR0315400A (pt) | 2005-08-16 |
| EP1556374A2 (en) | 2005-07-27 |
| US20080146648A1 (en) | 2008-06-19 |
| IL168059A0 (en) | 2009-02-11 |
| US7589119B2 (en) | 2009-09-15 |
| US20060194866A1 (en) | 2006-08-31 |
| US7358274B2 (en) | 2008-04-15 |
| AU2003286441A1 (en) | 2004-05-04 |
| KR20050072764A (ko) | 2005-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1678166T3 (pl) | Inhibitory kinaz białkowych | |
| WO2001064639A3 (en) | Pde iv inhibiting amides, compositions and pharmaceutical use | |
| PL1635835T3 (pl) | Pochodne 2-aminopirymidyny jako inhibitory kinazy RAF | |
| IL166298A0 (en) | 8-hydroxy quinoline derivatives | |
| MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| GB0112348D0 (en) | Compounds | |
| WO2004084812A3 (en) | Tamandarin analogs and fragments thereof and methods of making and using | |
| MXPA05009303A (es) | Formas de dosificacion y procedimientos de tratamiento que usan inhibidores del vegfr. | |
| DE69907419D1 (en) | Antitumorwirkstoffe | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| AP2002002466A0 (en) | 3-heterocycliylpropanohydroxamic acid PCP INHIBITORS. | |
| AU2001277659A1 (en) | Heteropolycyclic inhibitors | |
| AU2003300385A8 (en) | Anticancer compounds | |
| MXPA05003909A (es) | Compuestos de benzopiranona, composiciones de los mismos, y metodos para el tratamiento o prevencion del cancer. | |
| WO2004075858A3 (en) | Flavone acetic acid analogs and methods of use thereof | |
| GB2426517A (en) | Methods and agents for inhibiting dynamin-dependent endocytosis | |
| IL156140A0 (en) | Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence | |
| TW200730177A (en) | 4 anilino-3-quinolinecarbonitriles for the treatment of cancer | |
| AU2003216965A1 (en) | Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases | |
| ATE314059T1 (de) | VERWENDUNG VON ßXYLYLOXY ALKYL AMINESß FÜR DIE BEHANDLUNG VON TINNITUS | |
| HK1114854A (en) | Benzopyranone compounds for treating cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |